FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987445982> ?p ?o ?g. }

• W2987445982 endingPage "2907" @default.
• W2987445982 startingPage "2907" @default.
• W2987445982 abstract "Background and Objectives:Cancer associated malnutrition and cachexia is an important determinant of the patient's short and long term outcomes. This prospective study was conducted to determine the association between cachexia at diagnosis and overall survival of patients with aggressive B-cell non-Hodgkin's Lymphoma (ABNHL) Methods:This investigator initiated single centre prospective observational study was conducted at the Tata Medical Center, Kolkata, India between Jan 2015 and Mar 2019 after IRB approval. Patients diagnosed with ABNHL receiving standard of care chemo-immunotherapy were eligible. This study was supported by an educational research grant from Baxter to our institution. All patients who consented to participate were screened for cachexia at entry using a modified Subjective Global Assessment (SGA) tool (1). Baseline clinical factors of prognostic importance including stage, IPI score, etc. were recorded. All statistical analysis was carried out using EpiInfo-ver.7 software. Results:239 patients diagnosed with high grade B-NHL were recruited. The study group included 89 women and 150 men, and 77 (32.1%) were older than 65 years. 130 (54.3%) patients received private care. 88(36.8%) had IPI stage high-intermediate plus high grade; 136 (56.9%) had Ann Arbor stage III plus IV disease; 40 (16.7%) had extra-nodal NHL; 96 (40.1%) had weight loss and 107(44.7%) had reduced food intake. Cachexia scores estimated by the modified SGA tool was SGA-A in 101, SGA-B in 120 and SGA-C in 18 patients. Only 37 (15.4%) had been subjected to screening for malnutrition prior to cancer treatment. 44 (20.5%) patients experienced neutropenic sepsis during treatment. At a median follow up of 457 days, 69% achieved complete remission at the end of initial therapy, 50 (20.9%) patients died during the study period. In univariate analysis, SGA, IPI, Stage and age groups were statistically significant prognostic markers. The 2-year actuarial survival of all patients adjusted for SGA, IPI and Stage was 72%. The two-year actuarial survival in the SGA-A, SGA-B, and SGA-C groups were respectively 80%, 68% and 45% (p<0.001). In a multivariate analysis using cox proportional hazards method the hazard ratio for SGA B was 1.67 (0.94-2.97), and SGA-C was 3.65, after adjusting for IPI and stage groups (p=0.0137).The follow up is continuing and final multivariate analysis will be done when sufficient events have occurred. Conclusions:Cachexia at diagnosis is an important independent prognostic biomarker in patients with ABNHL. The role of routine screening for cachexia before initiating treatments and providing individualized medical nutrition therapy along with physical therapy during chemotherapy to prevent worsening of cachexia and improve survival needs evaluation. References: 1.Shirodkar M etal, Indian J Gastroenterol.2005; 24:246-50 Figure Disclosures Patra: Baxter: Research Funding. Mallath:Otsuka Pharmaceuticals: Consultancy, Membership on an entity's Board of Directors or advisory committees; Pfizer: Speakers Bureau; GlaxoSmithKline: Research Funding; Baxter: Research Funding; Otsuka Pharmaceuticals: Honoraria; Bristol-Myers Squibb: Honoraria; Bayer-Zydus Pharma: Honoraria; Sayre-Therapeutics: Honoraria." @default.
• W2987445982 created "2019-11-22" @default.
• W2987445982 creator A5001692980 @default.
• W2987445982 creator A5041850330 @default.
• W2987445982 creator A5067147178 @default.
• W2987445982 creator A5068225545 @default.
• W2987445982 creator A5074194089 @default.
• W2987445982 creator A5078411303 @default.
• W2987445982 date "2019-11-13" @default.
• W2987445982 modified "2023-09-26" @default.
• W2987445982 title "Cachexia at Diagnosis adversely predicts outcomes in patients with Aggressive B-Cell NHL receiving standard of care treatment: A Prospective Observational Study from India" @default.
• W2987445982 doi "https://doi.org/10.1182/blood-2019-126295" @default.
• W2987445982 hasPublicationYear "2019" @default.
• W2987445982 type Work @default.
• W2987445982 sameAs 2987445982 @default.
• W2987445982 citedByCount "0" @default.
• W2987445982 crossrefType "journal-article" @default.
• W2987445982 hasAuthorship W2987445982A5001692980 @default.
• W2987445982 hasAuthorship W2987445982A5041850330 @default.
• W2987445982 hasAuthorship W2987445982A5067147178 @default.
• W2987445982 hasAuthorship W2987445982A5068225545 @default.
• W2987445982 hasAuthorship W2987445982A5074194089 @default.
• W2987445982 hasAuthorship W2987445982A5078411303 @default.
• W2987445982 hasConcept C121608353 @default.
• W2987445982 hasConcept C126322002 @default.
• W2987445982 hasConcept C187212893 @default.
• W2987445982 hasConcept C188816634 @default.
• W2987445982 hasConcept C23131810 @default.
• W2987445982 hasConcept C2777704314 @default.
• W2987445982 hasConcept C511355011 @default.
• W2987445982 hasConcept C544821477 @default.
• W2987445982 hasConcept C71924100 @default.
• W2987445982 hasConceptScore W2987445982C121608353 @default.
• W2987445982 hasConceptScore W2987445982C126322002 @default.
• W2987445982 hasConceptScore W2987445982C187212893 @default.
• W2987445982 hasConceptScore W2987445982C188816634 @default.
• W2987445982 hasConceptScore W2987445982C23131810 @default.
• W2987445982 hasConceptScore W2987445982C2777704314 @default.
• W2987445982 hasConceptScore W2987445982C511355011 @default.
• W2987445982 hasConceptScore W2987445982C544821477 @default.
• W2987445982 hasConceptScore W2987445982C71924100 @default.
• W2987445982 hasIssue "Supplement_1" @default.
• W2987445982 hasLocation W29874459821 @default.
• W2987445982 hasOpenAccess W2987445982 @default.
• W2987445982 hasPrimaryLocation W29874459821 @default.
• W2987445982 hasRelatedWork W1750391852 @default.
• W2987445982 hasRelatedWork W2078332276 @default.
• W2987445982 hasRelatedWork W2329707895 @default.
• W2987445982 hasRelatedWork W2399746673 @default.
• W2987445982 hasRelatedWork W2437391300 @default.
• W2987445982 hasRelatedWork W3081961945 @default.
• W2987445982 hasRelatedWork W3144674925 @default.
• W2987445982 hasRelatedWork W3163383853 @default.
• W2987445982 hasRelatedWork W3217069434 @default.
• W2987445982 hasRelatedWork W2612605095 @default.
• W2987445982 hasVolume "134" @default.
• W2987445982 isParatext "false" @default.
• W2987445982 isRetracted "false" @default.
• W2987445982 magId "2987445982" @default.
• W2987445982 workType "article" @default.